Why are Medicare and Medicaid shown separately instead of combined?

They come from two different CMS data sources with no shared claim identifier, so they can't be reconciled into one number without double-counting or guessing. Every table and chart on this page keeps them fully separate.

Why is there no private/commercial revenue figure?

Private and commercial payer data comes from Transparency in Coverage files, which only publish negotiated rates — not claims or utilization volume. Without a volume figure, no revenue number can be computed for any provider from that data.

What does "Rank" mean in the Competitive Analysis & Benchmarks tables?

For a given CPT/HCPCS code, it's this provider's position by claims volume among all providers billing that same code at that geography level (State, National, or Arizona for Medicaid) — rank 1 means the highest claims volume for that code.

Why is the Medicaid comparison limited to Arizona only?

Medicaid is administered per-state with no single national fee schedule, so a state or national comparison the way Medicare has one isn't available. Arizona (this provider's own state) is the only grouping that's conceptually meaningful.

Why are the numbers rounded to the nearest 10?

To avoid implying more precision than the underlying data supports at a single-provider level. Ratios are kept precise since they're a relative comparison, not a volume or dollar figure.

How current is this data?

The Medicare and Medicaid tables are both single current snapshots, not refreshed on a recurring schedule yet.

Ronald Hobbs (NPI 1194986786)

Field	Value
Entity Type	Individual
Organization	Ronald Hobbs
Address	6242 E Arbor Ave Ste 107
City	Mesa
State	AZ
ZIP	85206
Taxonomy	Ophthalmology Physician
NPI Enumerated	June 17, 2008

Payer Source	Total Paid
Medicare	$4.1M
Medicaid	$0

Key Findings

This provider’s Medicare activity is concentrated in intravitreal pharmaceutical treatments: J0178 (aflibercept) and J2777 (faricimab-svoa) together account for a large share of receipts, with the precomputed top 3 codes representing 80.0% of total Medicare revenue. The dominance of anti-VEGF and related intravitreal injection codes indicates a practice focused on medical retina services rather than primarily surgical or general ophthalmology care.

Total Medicare revenue is $4.1M while there is no Medicaid billing on file, so this provider is effectively single-payer from a public-program perspective, with Medicare as the only recorded public reimbursement source. Absence of Medicaid billing suggests a limited role in low-income or dual-eligibility patient billing within available state datasets.

J0178 generates $1.8M (44.5% of Medicare revenue) and the provider ranks #277 of 3204 nationally (91th percentile) for that code, which the data labels as typical, unremarkable volume; this indicates solid but not dominant national standing for aflibercept administration. Similarly, J2777 produced $1.2M (29.1% of Medicare revenue) with a rank of #162 of 2039 providers (92th percentile) and is also characterized as typical volume, reinforcing that most revenue comes from commonly rendered intravitreal therapies rather than unusually high market share.

Procedure and imaging codes such as 67028 ($263.5K, 6.5% of Medicare revenue) and 92134 ($128.5K, 3.2%) appear at notably higher relative volumes: 67028 ranks #105 of 4255 providers (98th percentile) and is described as notably above typical national volume, while 92134 ranks #103 of 26868 providers (100th percentile) and is an extreme outlier. This combination suggests the clinician not only administers frequent injections but also performs a high volume of associated retinal procedures and diagnostic imaging, consistent with an active retinal practice.

Several non-specific and compounded drug codes appear in the mix: J3490 produced $187.3K (4.6% of Medicare revenue) at the 74th percentile and J7999 produced $102.2K (2.5%) at the 98th percentile. The presence of these unclassified and compounded drug codes at above-typical volume implies additional revenue from miscellaneous or compounded intravitreal agents beyond the primary anti-VEGF products.

Evaluation and management exams are present but secondary to injection work: 92014 accounted for $155K (3.8% of Medicare revenue) with an extreme outlier ranking (#348 of 35415, 99th percentile) and 92004 accounted for $31.9K (0.8%) also at the 99th percentile. High-volume established and new patient comprehensive exams alongside the injection codes indicate the provider handles both ongoing injection follow-up visits and initial consultations at volumes well above typical national peers.

Provider tenure is long-standing: the NPI was enumerated on 2008-06-17 (~18 years ago), indicating nearly two decades of Medicare participation and suggesting an established practice and referral base in Mesa, AZ. This longevity, combined with high-volume retina procedure and imaging codes, supports a stable, subspecialized ophthalmology practice focused on medical retina care.

Competitive standing across codes is mixed: for core injection codes the provider sits in the 91st–92nd percentiles (typical, unremarkable volume), while for certain associated procedures and exams the provider is in the highest percentiles (98th–100th) and described as notably above typical or extreme outlier. This pattern indicates a concentrated specialist who achieves regional dominance in retinal diagnostics and procedure volume even if their national ranking for specific drugs is not at the very top.

Medicare: Complete Services Breakdown

The CPT/HCPCS codes generating the most Medicare revenue for this provider.

16 rows

CPT/HCPCS Code	Description	Claims	Avg Paid	Revenue
J0178	Injection, aflibercept, 1 mg	2,610	$690	$1.8M
J2777	Injection, faricimab‑svoa, 0.1 mg	40,740	$30	$1.2M
67028	The provider injects a medication into the vitreous chamber of the eye as an isolated procedure or a separate procedure unrelated to any other procedure being performed on the eye.	2,930	$90	$263.5K
J3490	Unclassified drugs	110	$1,770	$187.3K
92014	An ophthalmologist sees an established patient for a comprehensive level eye examination. Generally, a patient is considered to be "established" if the same physician, or any physician in the group…	1,820	$90	$155K
92134	The provider performs computerized diagnostic imaging of the retina in the posterior segment (back part) of the eye, interprets the data, and provides a report. The service may be on one or both eyes.	4,280	$30	$128.5K
J7999	Compounded drug, not otherwise classified	1,440	$70	$102.2K
J2781	Injection, pegcetacoplan, intravitreal, 1 mg	620	$120	$73.8K
J2778	Injection, ranibizumab, 0.1 mg	340	$180	$61K
J7312	Injection, dexamethasone, intravitreal implant, 0.1 mg	340	$160	$53.1K

Showing 1–10 of 16

Medicare: Competitive Analysis & Benchmarks

How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 16 CPT/HCPCS codes.

View: State1 / 2

Claims Volume vs. Arizona Distribution

Ronald Hobbs — 4 of 16 codes billed far more than typical (above p95)

p5–p95 (all providers)p25–p75MedianThis providerOutlier

Rank Distribution — Arizona

Full comparison — all codes billed, vs. state median

16 rows

CPT/HCPCS Code	Rank	Provider Count	Median Claims	Avg Paid	Average Revenue
J0178	5	50	780	$690	$734.8K
J2777	1	50	9,000	$30	$525.8K
J2778	9	30	550	$180	$198K
67028	1	60	1,240	$90	$119K
J2781	12	10	650	$120	$92.4K
67041	8	20	30	$1,220	$51K
J7312	5	20	270	$160	$48.9K
J7999	1	50	490	$70	$46.8K
92014	1	650	140	$80	$21.5K
J3490	10	100	40	$90	$17.1K

Showing 1–10 of 16

Related Providers

Other providers that share a Tax Identification Number (TIN) with Ronald Hobbs, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Barnet Dulaney Perkins Eye Center, PC	AZ	Ophthalmology Physician	$0	$10.9M
Sujit Itty	AZ	Ophthalmology Physician	$6.2M	$11.3K
Neal Palejwala	AZ	Ophthalmology Physician	$4.4M	$2.9K
Sachin Mehta	AZ	Retina Specialist (Ophthalmology) Physician	$4.4M	$11.8K
Barnet Dulaney Perkins Eye Center, PC	AZ	Ambulatory Surgical Clinic/Center	$2.8M	$1.1M
Mahmood El-gasim	AZ	Uveitis and Ocular Inflammatory Disease (Ophthalmology) Physician	$3.7M	$0
Brendan Girschek	AZ	Ophthalmology Physician	$3.2M	$0
Mark Barakat	AZ	Ophthalmology Physician	$3M	$0
Jordan Graff	AZ	Retina Specialist (Ophthalmology) Physician	$2.8M	$0
Suhail Alam	AZ	Retina Specialist (Ophthalmology) Physician	$2.5M	$0

Nearby Providers

Other providers in the same ZIP code as Ronald Hobbs, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Acumen Fiscal Agent LLC	AZ	Community/Behavioral Health Agency	$0	$1.1B
Affinity Family Care, LLC.	AZ	Home Health Agency	$0	$63.8M
Residents At The Heights, LLC	AZ	Substance Abuse Rehabilitation Facility	$0	$33.2M
Banner Baywood Medical Center	AZ	General Acute Care Hospital	$0	$29.6M
A Brighter Avenue LLC	AZ	Speech-Language Pathologist	$0	$28.6M
Emergency Physicians Southwest, PC	AZ	Emergency Medicine Physician	$0	$27M
Health Care Alternatives, Inc.	AZ	Intellectual and/or Developmental Disabilities Residential Treatment Facility	$0	$26.1M
Christian3 Mega Clinic LLC	AZ	Substance Use Disorder Rehabilitation Clinic/Center	$0	$22.3M
Horizon Pediatric Therapy, Inc.	AZ	Music Therapist	$0	$17.9M
Zarephath Inc.	AZ	Community/Behavioral Health Agency	$0	$17M

Ronald Hobbs — Billing Profile & Reimbursement Data

Sign up for Ronald Hobbs — Billing Profile & Reimbursement Data policy alerts

Ronald Hobbs — Billing Profile & Reimbursement Data

Sign up for Ronald Hobbs — Billing Profile & Reimbursement Data policy alerts

Key Findings

Medicare: Total Revenue Breakdown by CPT/HCPCS Code

Medicare: Complete Services Breakdown

Medicare: Competitive Analysis & Benchmarks

Related Providers

Nearby Providers

Frequently Asked Questions

References